Incarceration and drug use patterns among a cohort of injection drug users

Addiction

Volumn 104, Issue 1, 2009, Pages 69-76

  DeBeck, Kora ^b   Kerr, Thomas ^b   Li, Kathy ^b   Milloy, M J ^b   Montaner, Julio ^b   Wood, Evan ^a,b  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Addiction treatment; Deterrence; Drug law enforcement; Drug policy; Drug use patterns; Incarceration; Injection cessation; Injection drug use

Indexed keywords

COCAINE; DIAMORPHINE; METHADONE;

ADULT; ARTICLE; CANADA; COCAINE DEPENDENCE; COHORT ANALYSIS; DRUG ABUSE; FEMALE; FOLLOW UP; HEROIN DEPENDENCE; HUMAN; INTRAVENOUS DRUG ABUSE; LAW ENFORCEMENT; MAJOR CLINICAL STUDY; MALE; POLICY; PREVALENCE;

ADULT; EPIDEMIOLOGIC METHODS; FEMALE; HIV INFECTIONS; HUMANS; INSTITUTIONALIZATION; LAW ENFORCEMENT; MALE; METHADONE; NARCOTICS; POLICY MAKING; PREVALENCE; PRISONS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 57649128374     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2008.02387.x     Document Type: Article

References (43)

1. Macdonald Z., Tinsley L., Collingwood J., Jamieson P., Pudney S. Measuring the Harm from Illegal Drugs Using the Drug Harm Index. London : Home Office 2005.
2. Government of Canada. Canada's Drug Strategy. Ottawa : Minister of Public Works and Government Services Canada 1998.
3. Boyum D., Reuter P. An Analytic Assessment of U.S. Drug Policy. Washington, DC : American Enterprise Institute for Public Policy Research 2005.
4. DeBeck K., Wood E., Montaner J., Kerr T. Canada's 2003 renewed drug strategy - an evidence-based review. HIV AIDS Policy Law Rev 2006 11 : 5 12.
5. Weatherburn D. Performance Indicators for Drug Law Enforcement. Sydney : Bureau of Crime Statistics and Research New South Wales 2000. http://search.informit.com.au/documentSummary;dn=915983327019492;res=IELHSS (accessed 21 November 2008).
6. Bewley-Taylor D., Trace M., Stevens A. Incarceration of Drug Offenders: Costs and Impacts. Briefing paper no. 7. Surrey, UK : Beckley Foundation Drug Policy Programme 2005.
7. The White House. National Drug Control Strategy. Washington, DC : The White House 2007. http://www.whitehousedrugpolicy.gov/publications/policy/ ndcs07/ndcs07.pdf (accessed 21 November 2008).
8. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Annual Report: the State of the Drugs Problem in Europe. Lisboa, Portugal : EMCDDA 2006.
9. Public Safety and Emergency Preparedness Portfolio Corrections Statistics Committee. Corrections and Conditional Release Statistical Overview. Ottawa, Canada : Public Safety and Emergency Preparedness Canada 2004.
10. US Department of Justice, Office of Justice Programs Bureau of Justice Statistics. Prison Statistics. 2007. Available at: http://www.ojp.gov/bjs/ prisons.htm (accessed 8 August 2007).
11. Harrison P., Beck A. Prisoners in 2005. NCJ 215092. Washington, DC : US Department of Justice, Bureau of Justice Statistics 2006.
12. Rehm J., Baliunas D., Brochu S., Fischer B., Gnam W., Patra J. et al. The Costs of Substance Abuse in Canada 2002. Ottawa, ON : Canadian Centre on Substance Abuse 2006.
13. Office of the Prime Minister. Speech, 4 October 2007: Prime Minister pledges crackdown on drug criminals, compassion for their victims. Government of Canada. 2007. Available at: http://news.gc.ca/web/view/en/index.jsp?articleid= 352609& (accessed 9 October 2007).
14. National Research Council. Executive summary of the National Research Council's report informing America's policy on illegal drugs: what we don't know keeps hurting us. Addiction 2002 97 : 647 52.
15. Strathdee S., Patrick D., Currie S., Cornelisse P., Rekart M., Montaner J. et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997 11 : F59 65.
16. Shah N., Celentano D., Vlahov D., Stambolis V., Johnson L., Nelson K. et al. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS 2000 14 : 2035 43.
17. Kerr T., Marsh D., Li K., Montaner J., Wood E. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver. Drug Alcohol Depend 2005 80 : 329 35.
18. Fitzmaurice G. M., Laird N. M., Ware J. H. Applied Longitudinal Analysis. Hoboken, NJ : Wiley-Interscience 2004.
19. Susser M. Commentary: the longitudinal perspective and cohort analysis. Int J Epidemiol 2001 30 : 684 7.
20. Galai N., Safaeian M., Vlahov D., Bolotin A., Celentano D. Longitudinal patterns of drug injection behavior in the ALIVE Study cohort,1988-2000: description and determinants. Am J Epidemiol 2003 158 : 695 704.
21. Roy E., Boudreau J. F., Leclerc P., Boivin J. F., Godin G. Trends in injection drug use behaviors over 10 years among street youth. Drug Alcohol Depend 2007 89 : 170 5.
22. Wood E., Stoltz J. A., Li K., Montaner J. S., Kerr T. Changes in Canadian heroin supply coinciding with the Australian heroin shortage. Addiction 2006 101 : 689 95.
23. Fairbairn N., Kerr T., Buxton J. A., Li K., Montaner J. S., Wood E. Increasing use and associated harms of crystal methamphetamine injection in a Canadian setting. Drug Alcohol Depend 2007 88 : 313 6.
24. Rachlis B. S., Wood E., Li K., Hogg R. S., Kerr T. Drug and HIV-related risk behaviors after geographic migration among a cohort of injection drug users. AIDS Behav 2008 published online 22 April 2008, epub ahead of print.
25. Vlahov D., Safaien M., Lai S., Strathdee S., Johnson L., Sterling T. et al. Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users. AIDS 2001 15 : 2311 6.
26. Hoffmann J., Su S., Pach A. Changes in network characteristics and HIV risk behavior among injection drug users. Drug Alcohol Depend 1997 46 : 41 51.
27. Sturmer T., Joshi M., Glynn R. J., Avorn J., Rothman K. J., Schneeweiss S. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol 2006 59 : 437 47.
28. Bruneau J., Brogly S., Tyndall M., Lamothe F., Franco E. Intensity of drug injection as a determinant of sustained injection cessation among chronic drug users: the interface with social factors and service utilization. Addiction 2004 99 : 727 37.
29. Sherman S., Hua W., Latkin C. Individual and environmental factors related to quitting heroin injection. Subst Use Misuse 2004 39 : 1199 214.
30. Blankenship K., Koester S. Criminal law, policing policy, and HIV risk in female street sex workers and injection drug users. J Law Med Ethics 2002 30 : 548 59.
31. Galai N., Safaeian M., Vlahov D., Bolotin A., Celentano D. Longitudinal patterns of drug injection behavior in the ALIVE study cohort,1988-2000: description and determinants. Am J Epidemiol 2003 158 : 695 704.
32. Deren S., Kang S., Colon H., Robles R. Predictors of injection drug use cessation among Puerto Rican drug injectors in New York and Puerto Rico. Am J Drug Alcohol Abuse 2007 33 : 291 9.
33. General Secretariat. European Union Drug Strategy (2005-12). 15074/04. Council of the European Union. 2004. Available at: http://www.emcdda.europa.eu/ index.cfm?nNodeID=6790 (accessed 10 November 2007).
34. Smoyer A., Blankenship K. Drug Policy: Definition, Discussion and State Variation. Policy update. New Haven, CT : Yale University Centre for Interdisciplinary Research on AIDS 2004.
35. Clarke J., Stein M., Hanna L., Sobota M., Rich J. Active and former injection drug users report of HIV risk behaviors during periods of incarceration. Subst Abuse 2001 22 : 209 16.
36. Andía J., Deren S., Robles R., Kang S., Colón H., Oliver-velez D. et al. Factors associated with injection and noninjection drug use during incarceration among Puerto Rican drug injectors in New York and Puerto Rico. Prison J 2005 85 : 329 42.
37. Buavirat A., Page-Shafer K., van Griensven G., Mandel J., Evans J., Chuaratanaphong J. et al. Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ 2003 326 : 308.
38. Small W., Kain S., Laliberte N., Schechter M. T., O'Shaughnessy M. V., Spittal P. M. Incarceration, addiction and harm reduction: inmates experience injecting drugs in prison. Subst Use Misuse 2005 40 : 831 43.
39. Estebanez P., Zunzunegui M., Aguilar M., Russell N., Cifuentes I., Hankins C. The role of prisons in the HIV epidemic among female injecting drug users. AIDS Care 2002 14 : 95 104.
40. Tyndall M., Currie S., Spittal P., Li K., Wood E., O'Shaughnessy M. et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 2003 17 : 887 93.
41. Hagan H. The relevance of attributable risk measures to HIV prevention planning. AIDS 2003 17 : 911 3.
42. Walmsley R. World Prison Population List. London, UK : Home Office 2003.
43. Gelman A., Stern H. The difference between 'significant' and 'not significant' is not itself statistically significant. Am Stat 2006 60 : 328 31.